Transfusion and hemovigilance in pediatrics

Pediatric Clinics of North America

Volumn 60, Issue 6, 2013, Pages 1527-1540

  Bolton Maggs, Paula H B ^a  

^a Serious Hazards of Transfusion   (United Kingdom)

Author keywords

Complications of transfusion; Hemovigilance; Pediatric transfusion; Root cause analysis; SHOT

Indexed keywords

ALLERGY; BACTERIAL INFECTION; BETA THALASSEMIA; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHILDHOOD DISEASE; DISEASE SURVEILLANCE; GOVERNMENT; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HEMOLYSIS; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; LIFE EXPECTANCY; MEDICAL PRACTICE; MEDICATION ERROR; NECROTIZING ENTEROCOLITIS; PATIENT SAFETY; PREGNANT WOMAN; REVIEW; RISK FACTOR; SCREENING TEST; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY;

COMPLICATIONS OF TRANSFUSION; HEMOVIGILANCE; PEDIATRIC TRANSFUSION; ROOT CAUSE ANALYSIS; SHOT;

ADOLESCENT; BLOOD SAFETY; BLOOD TRANSFUSION; CHILD; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL ERRORS; PATIENT SAFETY; QUALITY ASSURANCE, HEALTH CARE; RISK MANAGEMENT;

EID: 84887521514     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2013.08.010     Document Type: Review

References (44)

1. Biggs R. Jaundice and antibodies directed against factors 8 and 9 in patients treated for haemophilia or Christmas disease in the United Kingdom. Br J Haematol 1974, 26:313-329.
2. Ammann A.J., Cowan M.J., Wara D.W., et al. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet 1983, 1:956-958.
3. Curran J.W., Lawrence D.N., Jaffe H., et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. NEngl J Med 1984, 310:69-75.
4. Saulsbury F.T., Wykoff R.F., Boyle R.J. Transfusion-acquired human immunodeficiency virus infection in twelve neonates: epidemiologic, clinical and immunologic features. Pediatr Infect Dis J 1987, 6:544-549.
5. Holland P.V., Richards C.A., Teghtmeyer J.R., et al. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits. Transfusion 1985, 25:395-397.
6. Zou S., Dorsey K.A., Notari E.P., et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010, 50:1495-1504.
7. Biggerstaff B.J., Petersen L.R. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003, 43:1007-1017.
8. O'Brien S.F., Zou S., Laperche S., et al. Surveillance of transfusion-transmissible infections comparison of systems in five developed countries. Transfus Med Rev 2012, 26:38-57.
9. McClelland D.B., Phillips P. Errors in blood transfusion in Britain: survey of hospital haematology departments. BMJ 1994, 308:1205-1206.
10. Wells A.W., Mounter P.J., Chapman C.E., et al. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002, 325:803.
11. American Association of Blood Banks. The 2009 National Blood Collection andUtilization Survey Report. Available at: Accessed June 3, 2013. http://wwwaabborg/programs/biovigilance/nbcus/Documents/09-nbcus-reportpdf%202009.
12. Wiersum-Osselton J.C., van Tilborgh-de Jong A.J., Zijlker-Jansen P.Y., et al. Variation between hospitals in rates of reported transfusion reactions: is a high reporting rate an indicator of safer transfusion?. Vox Sang 2013, 104:127-134.
13. Serious Hazards of Transfusion. SHOT Definitions. Available at: Accessed June 6, 2013. http://www.shotuk.org/wp-content/uploads/2010/03/SHOT-definitions-Nov012-finalpdf.
14. International Society of Blood Transfusion/International Haemovigilance Network, Haemovigilance Working Party. Proposed standard definitions for surveillance of non-infectious adverse transfusion reactions. Available at: Accessed September 30, 2013. http://www.isbtweb.org/fileadmin/user_upload/WP_on_Haemovigilance/ISBT_definitions_final_2011__4_.pdf%202011.
15. Wagner S.J. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004, 86:157-163.
16. Love E, Soldan K, Jones H. SHOT annual report 2000/2001. Manchester; 2002. Available at: http://www.shotuk.org.
17. Strong DM, Lipton KS. AABB. Association Bulletin #06-07. Available at: Accessed September 30, 2013. http://www.bpro.or.jp/publication/pdf_jptrans/us/us200611en.pdf.
18. Bolton-Maggs P., Davies T., Poles D., et al. Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG 2013, 120:873-878.
19. Yazdanbakhsh K., Ware R.E., Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012, 120:528-537.
20. DH. Never Events List 2012/13-Transfusion of ABO-incompatible blood components 2012;17:13. Available at: Accessed September 30, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/142013/Never_events_201213.pdf.
21. Department of Health. Health Service Circular: Better Blood Transfusion. 1998. Available at: Accessed September 30, 2013. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirculars/DH_4004262.
22. Department of Health. Health Service Circular: Better Blood Transfusion - the appropriate use of blood. 2002. Available at: Accessed September 30, 2013. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirculars/DH_4004264.
23. Department of Health. Health Service Circular: Better Blood Transfusion - safeand appropriate use of blood. 2007. Available at: Accessed September 30, 2013. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_080803.pdf.
24. NCA. National Comparative Audit of Blood Transfusion - Re-audit of bedside transfusion practice 2011:1-75. Available at: Accessed September 30, 2013. http://hospital.blood.co.uk/library/pdf/NCA_2011_bedside_tx_re-audit_report.pdf.
25. Tinegate H., Birchall J., Gray A., et al. Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol 2012, 159:143-153.
26. British Committee for Standards in Haematology, Milkins C., Berryman J., et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 2013, 23:3-35.
27. Gibson B.E., Todd A., Roberts I., et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004, 124:433-453.
28. Verduzco L.A., Nathan D.G. Sickle cell disease and stroke. Blood 2009, 114:5117-5125.
29. Venkatesh V., Khan R., Curley A., et al. The safety and efficacy of red cell transfusions in neonates: a systematic review of randomized controlled trials. Br J Haematol 2012, 158:370-385.
30. McCoy T.E., Conrad A.L., Richman L.C., et al. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011, 17:347-367.
31. Whyte R.K., Kirpalani H., Asztalos E.V., et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009, 123:207-213.
32. Corwin H.L., Carson J.L. Blood transfusion-when is more really less?. NEngl J Med 2007, 356:1667-1669.
33. Lacroix J., Hebert P.C., Hutchison J.S., et al. Transfusion strategies for patients in pediatric intensive care units. NEngl J Med 2007, 356:1609-1619.
34. Slonim A.D., Joseph J.G., Turenne W.M., et al. Blood transfusions in children: a multi-institutional analysis of practices and complications. Transfusion 2008, 48:73-80.
35. NCA. National Comparative Audit of the use of Red Cells in Neonates and Children 2010. Available at: Accessed September 30, 2013. http://hospital.blood.co.uk/library/pdf/NCA_red_cells_neonates_children.pdf.
36. British Committee for Standards in Haematology. Guideline on the Administration of Blood Components. 2010. Available at: Accessed September 30, 2013. http://www.bcshguidelines.com/documents/Admin_blood_components_bcsh_05012010.pdf.
37. Stainsby D., Jones H., Wells A.W., et al. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol 2008, 141:73-79.
38. Christensen R.D. Association between red blood cell transfusions and necrotizing enterocolitis. JPediatr 2011, 158:349-350.
39. Blau J., Calo J.M., Dozor D., et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. JPediatr 2011, 158:403-409.
40. Ironside J.W. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 2012, 50:50-56.
41. JPAC. Methylene blue-treated Plasma: Joint UKBTS/HPA Professional Advisory Committee/Serious Hazards of Transfusion (SHOT) Position Statement. Available at: Accessed September 30, 2013. http://www.transfusionguidelines.org.uk/index.aspx?Publication=DL%26Section=12%26pageid=7737.
42. Bolton-Maggs PHB, Cohen H. The Annual SHOT Report (2011). 2012. Available at: http://www.shotuk.org.
43. Gawande A. The checklist manifesto 2009, Profile Books Ltd, London.
44. Haynes A.B., Weiser T.G., Berry W.R., et al. Asurgical safety checklist to reduce morbidity and mortality in a global population. NEngl J Med 2009, 360:491-499.